AMGEN BIOSIMILARS - Trademark Details
Status: 733 - Fourth Extension - Granted
Serial Number
88329711
Word Mark
AMGEN BIOSIMILARS
Status
733 - Fourth Extension - Granted
Status Date
2021-11-30
Filing Date
2019-03-07
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
090104 - Ribbons, bows.
Published for Opposition Date
2019-11-12
Attorney Name
Law Office Assigned Location Code
N10
Employee Name
MAHONEY, PAULA M
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"BIOSIMILARS"
Description of Mark
The mark consists of the stylized words "AMGEN BIOSIMILARS" positioned to the right of an interweaving double ribbon design.
Goods and Services
House mark for a full line of pharmaceuticals and pharmaceutical preparations, namely, pharmaceutical preparations and substances used for the treatment of bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune, immune system, inflammatory, inflammatory bowel, gastrointestinal, genitourinary, musculoskeletal, dermatological, pulmonary, respiratory, oncological, hepatological, lymphomas, leukemias, ophthalmic, transplant rejection, cardiovascular, endocrine, neurological, sleep, muscular, and psychiatric diseases and disorders;pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, polymyalgia rheumatic, spondyloarthropathies, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, autoimmune pancreatitis, multiple myeloma, multiple sclerosis, systemic lupus erythematosus, lupus nephritis, chronic inflammatory demyelinating polyneuropathy, autoimmune anemia, autoimmune hemolytic anemia, pure red cell aplasia, idiopathic thrombocytopenic purpura, Evans syndrome, type 1 diabetes mellitus, Sjogren's syndrome, encephalitis, IgG4-related disease, Devic's disease, myositis, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, palmoplantar psoriasis, hidradenitis suppurativa, bullous skin disorder, pemphigus, pemphigoid, kawasaki disease, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, age-related macular degeneration, refractory diabetic macular edema, uveitis, childhood uveitis, uveitic macular edema, choroidal neovascularization, Graves' ophthalmopathy, pyoderma gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancer, breast cancer, ovarian cancer, cervical cancer, gastric cancer, colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, head and neck cancer, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, lymphocyte predominant subtype of Hodgkin's Lymphoma, vasculitis, granulomatosis with polyangiitis, microscopic polyangiitis, graft-versus-host disease, graft-versus-host disease following allogenic hematopoietic stem cell transplantation, graft-versus-host disease following keratoprosthesis, kidney transplant, asthma, chronic fatigue syndrome, major depression, and bipolar depression
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-03-25
Primary Code
005
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Elsa D. Lemoine
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Prior Registration | 2170735 |
Prior Registration | 3226919 |
Prior Registration | 3921146 |
Trademark Events
Event Date | Event Description |
2019-03-11 | NEW APPLICATION ENTERED IN TRAM |
2019-03-25 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-03-26 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2019-03-26 | ASSIGNED TO EXAMINER |
2019-03-30 | NON-FINAL ACTION WRITTEN |
2019-03-30 | NON-FINAL ACTION E-MAILED |
2019-03-30 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-09-06 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-09-12 | ASSIGNED TO LIE |
2019-09-23 | ASSIGNED TO LIE |
2019-10-04 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-10-04 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-10-09 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-10-23 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-11-12 | PUBLISHED FOR OPPOSITION |
2019-11-12 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-01-07 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2020-03-02 | ASSIGNED TO EXAMINER |
2020-06-29 | TEAS EXTENSION RECEIVED |
2020-06-29 | EXTENSION 1 FILED |
2020-06-29 | EXTENSION 1 GRANTED |
2020-07-01 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-12-18 | TEAS EXTENSION RECEIVED |
2020-12-18 | EXTENSION 2 FILED |
2020-12-18 | EXTENSION 2 GRANTED |
2020-12-22 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-05-04 | TEAS EXTENSION RECEIVED |
2021-05-04 | EXTENSION 3 FILED |
2021-05-04 | EXTENSION 3 GRANTED |
2021-05-06 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-05-06 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2021-05-06 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2021-05-06 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
2021-05-06 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2021-11-30 | TEAS EXTENSION RECEIVED |
2021-11-30 | EXTENSION 4 FILED |
2021-11-30 | EXTENSION 4 GRANTED |
2021-12-02 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |